Fig. 1From: Novel target and treatment agents for natural killer/T-cell lymphomaCell-surface antigens as potential therapeutic targets for NKTCL. mAb: monoclonal antibody, ADC: antibody–drug conjugate, BiTE: bispecific T cell antigen, CAR: chimeric antigen receptor, LMP: latent membrane protein, PD-1: programmed cell death protein 1, PD-L1: programmed cell death ligand 1Back to article page